Rare diseases
Investigational molecules
Locations
Recruiting trials first
42 clinical trials in this condition
A Study of Baricitinib to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes
BelgiumA Study of Baricitinib to Delay Type 1 Diabetes in Children and Adults at Risk of Developing the Disease
BelgiumSafety and Pharmacokinetic Dose-Escalation Study of IMC-S118AI and Sodium Chloride in HLA‑A*02:01‑Positive Participants with Type 1 Diabetes
AustriaUsing glucagon and automated insulin delivery to prevent low blood sugar during exercise in adults with type 1 diabetes
DenmarkIn short
Type 1 diabetes diagnostics involve a range of tests that help identify the condition, distinguish it from other forms of diabetes, and monitor its progression. Early and accurate diagnosis can prevent life-threatening complications and enable timely treatment, while ongoing testing supports effective disease management throughout a person's life.
If you or someone you care about experiences symptoms like excessive thirst, frequent urination, unexplained weight loss, or extreme tiredness, it's important to see a healthcare provider promptly. These warning signs can appear suddenly, especially in children and young people, though they may develop more gradually in adults. Type 1 diabetes, a condition where the body's immune system attacks insulin-producing cells in the pancreas, requires prompt identification to avoid serious health problems.
Anyone experiencing these symptoms should seek medical attention as soon as possible and specifically ask to be tested for type 1 diabetes. While type 1 diabetes often develops in children, teenagers, and young adults, it can actually appear at any age, so adults should not dismiss the possibility. If you have a family member with type 1 diabetes, you may face a higher risk yourself. Testing is particularly advisable for first- and second-degree relatives of those already diagnosed with the condition, as underlying genetic risk is common within families.
Untreated diabetes can lead to very serious, even fatal, health problems, so it's crucial not to guess or delay. The symptoms of type 1 diabetes can resemble other health conditions, but a simple blood test can confirm whether diabetes is the cause. Seeking diagnostics early matters because it helps prevent a dangerous complication called diabetic ketoacidosis, which can occur when the disease goes undetected for too long.
Diagnosing type 1 diabetes involves several blood tests that measure glucose levels and help healthcare providers understand what's happening inside your body. The most common starting point is checking how much sugar is circulating in your blood at a given moment, and how that level has behaved over recent weeks or months. These tests are straightforward and provide clear answers about whether diabetes is present.
The A1C test, also known as glycated hemoglobin, is one of the primary tests used to diagnose type 1 diabetes. This blood test reveals your average blood sugar level over the past two to three months by measuring the percentage of blood sugar attached to hemoglobin, the oxygen-carrying protein in red blood cells. The higher your blood sugar levels have been, the more hemoglobin will have sugar attached to it. An A1C level of 6.5 percent or higher on two separate tests indicates diabetes.
However, the A1C test isn't always appropriate for everyone. If you're pregnant or have certain uncommon forms of hemoglobin, the test may give inaccurate results. In such cases, your healthcare provider will use other diagnostic methods to confirm the diagnosis.
A random blood sugar test takes a blood sample at any time of day, regardless of when you last ate. Blood sugar values are expressed in milligrams per deciliter or millimoles per liter. No matter when you last had food, a random blood sugar level of 200 milligrams per deciliter or higher suggests diabetes, especially when accompanied by typical symptoms. This test may be confirmed with additional testing to establish a definitive diagnosis.
For a fasting blood sugar test, a blood sample is taken after you haven't eaten overnight. A fasting blood sugar level below 100 milligrams per deciliter is considered healthy. Levels between 100 and 125 milligrams per deciliter suggest prediabetes, while a level of 126 milligrams per deciliter or higher on two separate tests confirms a diabetes diagnosis.
If you're diagnosed with diabetes, your provider may also run blood tests to check for autoantibodies, which are common in type 1 diabetes. These tests help distinguish between type 1 and type 2 diabetes when the diagnosis isn't immediately clear. Type 1 diabetes is an autoimmune condition where the body mistakenly attacks its own insulin-producing cells, and the presence of these autoantibodies confirms this immune system activity. Finding these antibodies supports a type 1 diagnosis rather than type 2, which has a different underlying cause.
The presence of ketones, which are byproducts from the breakdown of fat, in your urine also suggests type 1 diabetes rather than type 2. When your body can't use glucose for energy because of insufficient insulin, it starts breaking down fat instead, producing ketones. Detecting ketones in urine is another indicator that points toward type 1 diabetes.
It's important for doctors to correctly identify whether someone has type 1 or type 2 diabetes because the treatment approaches differ significantly. Type 1 diabetes always requires insulin therapy from the time of diagnosis because the pancreas produces little to no insulin. Type 2 diabetes, on the other hand, may initially be managed with oral medications and lifestyle changes. Tests for autoantibodies and ketones help make this distinction clear, ensuring that patients receive the right treatment from the start.
Adults with new-onset type 1 diabetes may present with symptoms similar to those seen in children but can experience a more gradual progression. This can sometimes lead to confusion with type 2 diabetes, which is more common in older populations. Diagnostic testing helps clarify the situation so that appropriate insulin therapy can begin without delay.
For individuals interested in participating in clinical trials for type 1 diabetes, specific diagnostic tests and criteria are typically required to determine eligibility. Clinical trials aim to study new treatments, therapies, or methods of managing type 1 diabetes, and researchers need to ensure that participants meet certain health and disease characteristics before enrollment.
Clinical trials commonly use blood glucose measurements and A1C levels as standard criteria for enrolling patients. Researchers may look for participants whose A1C levels fall within a certain range to ensure the trial is studying people with similar disease control. For example, some trials may seek individuals whose blood sugar is not well controlled, while others might focus on those who maintain tighter control. These measurements help create a more uniform study group.
Many clinical trials, especially those focused on disease prevention or early intervention, require autoantibody testing. Individuals with multiple type 1 diabetes-related autoantibodies are known to eventually develop clinical disease, so trials targeting early stages of the condition often recruit people who test positive for these antibodies but haven't yet developed full-blown diabetes. This allows researchers to study whether new therapies can delay or prevent disease onset.
Another common test used in clinical trial qualification is C-peptide testing, which measures how much insulin your pancreas is still producing. C-peptide is a substance released into the blood when the pancreas makes insulin. By measuring C-peptide levels, researchers can determine how much natural insulin production remains in a person with type 1 diabetes. Trials studying therapies to preserve or restore insulin production often require C-peptide testing to select participants at specific stages of disease progression.
Beyond these standard tests, clinical trials may require additional assessments such as kidney function tests, cardiovascular evaluations, or tests to check for diabetes-related complications. Researchers need to understand each participant's overall health to determine if they're suitable for the study and to monitor their response to the experimental treatment safely. Participants may also undergo regular blood glucose monitoring, continuous glucose monitoring, or other specialized testing as part of the trial protocol.
The outlook for people with type 1 diabetes has improved dramatically over the years thanks to advances in insulin therapy, glucose monitoring technology, and better understanding of disease management. While type 1 diabetes is a lifelong condition with no cure, many people live long, healthy, and fulfilling lives with proper treatment and care. The key to a good prognosis lies in maintaining blood glucose levels as close to the normal range as possible, which greatly reduces the risk of complications.
Consistently keeping glucose levels within target ranges helps prevent serious complications that can affect the eyes, kidneys, heart, blood vessels, and nerves. Close to half of people with type 1 diabetes will develop a serious complication over their lifetimes, but those who reach the first 20 years after diagnosis without any complications typically have a much better outlook going forward. This highlights the importance of early and aggressive glucose control from the time of diagnosis.
Long-term follow-up studies have shown that the benefits of early, intensive insulin therapy and tight glycemic control persist for several decades after treatment begins. People who maintain good control early in their disease experience lasting improvements in outcomes, including reduced risk of cardiovascular disease, kidney disease, and other complications. This lasting benefit underscores why proper management from the very beginning matters so much.
Mental health also plays an important role in the prognosis of type 1 diabetes. People with diabetes are two to three times more likely to experience depression and about 20 percent more likely to be diagnosed with anxiety compared to those without diabetes. Addressing mental health needs and providing emotional support are crucial components of comprehensive diabetes care and can significantly impact a person's ability to manage their condition effectively over time.
With modern treatment and management, the survival rate for people with type 1 diabetes has improved substantially. Research has demonstrated that intensive glycemic control reduces the risk of severe cardiovascular events, including nonfatal heart attack, stroke, or death from cardiovascular disease, by 57 percent over 11 years. Furthermore, intensive therapy has been associated with a decrease in all-cause mortality, meaning people who maintain tight blood sugar control live longer overall.
While type 1 diabetes does carry the risk of both short-term and long-term complications, proper management dramatically improves outcomes. Short-term complications like hypoglycemia and diabetic ketoacidosis can be life-threatening if not recognized and treated promptly, but with education and vigilance, these events can often be prevented or managed effectively. Long-term complications affecting the heart, kidneys, eyes, and nervous system develop over many years, but maintaining good glucose control from early in the disease significantly reduces these risks.
This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
